Merck Research Grants Program for Scientists

In 2021, we are offering a series of research grants to stimulate innovative research in difficult areas of future importance. Grants of € 40,000 to € 450,000 per year for a maximum of 3 years are available in the areas specified below.

  • Drug Discovery  – 3 grants of € 350,000 / year for 3 years with option to extend.
  • Real-time tests and sensors   – grant between $ 100,000 and $ 500,000 / year for 2 years with option to extend
  • Nanoparticle for nucleic acid delivery –   grant between $ 100,000 and $ 300,000 / year for 2 years with option to extend
  • Digital innovation –  3 grants of 40,000 to 100,000 € for 1 year with extension option
  • Bioelectronics –   grant of 150,000 € / year for 3 years
  • Sustainability  – grant (s) to be negotiated on a case-by-case basis
  • Recycling of media for cultured meat  – subsidy (s) to be negotiated on a case-by-case basis
  • Organoids   – subsidy (s) to be negotiated on a case-by-case basis

ABOUT 2021 RESEARCH GRANTS

The Merck Research Grants Program is open to scientists at all stages of their careers, affiliated with any research institution, university or company. Applicants submit their applications for priority topics containing only non-confidential information. You can apply for more than one grant or submit your application for more than one central topic. If your application is successful, you are invited to submit a full proposal in confidence and participate in an in-depth workshop with the other finalists. All applicants will be informed of the selection committee’s decision in early October.

The submission deadline is August 31, 2021.

DEEP DIVING WORKSHOPS

The in-depth workshops will take place in November and December 2021. Finalists will work with Merck managers and scientists to jointly optimize submitted project proposals. The culmination of the in-depth workshops will be the selection of the scholarship winners.

How to register? 

For more information, visit the  official website

Check Also

2022 SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical Fellowship

Cette bourse clinique soutient un diplôme en médecine ou un diplôme combiné MD / PhD et a un intérêt direct à faire avancer la recherche et la traduction d'approches immunothérapeutiques pour le traitement des patients atteints d'un cancer du poumon.

Leave a Reply

Your email address will not be published. Required fields are marked *